Price Alert

iBio Inc. (IBIO)

NASDAQ: IBIO · Real-Time Price · USD

0.88

0.05 (5.67%)

At close: Sep 10, 2025, 3:59 PM

0.86

-2.57%

Pre-market: Sep 11, 2025, 05:53 AM EDT

iBio Statistics

Share Statistics

iBio has 16.53M shares outstanding. The number of shares has increased by 88.08% in one year.

Shares Outstanding	16.53M
Shares Change (YoY)	88.08%
Shares Change (QoQ)	64.25%
Owned by Institutions (%)	26.23%
Shares Floating	15.64M
Failed to Deliver (FTD) Shares	39,003
FTD / Avg. Volume	1.49%

Short Selling Information

The latest short interest is 1.13M, so 5.75% of the outstanding shares have been sold short.

Short Interest	1.13M
Short % of Shares Out	5.75%
Short % of Float	5.76%
Short Ratio (days to cover)	1.64

Valuation Ratios

PE Ratio	0
Forward PE	-1.44
PS Ratio	20.03
Forward PS	18.2
PB Ratio	0.54
P/FCF Ratio	-0.52
PEG Ratio	0

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for iBio.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.18.

Current Ratio	1.59
Quick Ratio	1.59
Debt / Equity	0.18
Debt / EBITDA	-0.15
Debt / FCF	-0.18
Interest Coverage	86.68

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$25K
Profits Per Employee	n/a
Employee Count	16
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	0%

Stock Price Statistics

The stock price has increased by -53.68% in the last 52 weeks. The beta is 0.86, so iBio's price volatility has been higher than the market average.

Beta	0.86
52-Week Price Change	-53.68%
50-Day Moving Average	0.74
200-Day Moving Average	2.04
Relative Strength Index (RSI)	62.75
Average Volume (20 Days)	2,610,503

Income Statement

In the last 12 months, iBio had revenue of 400K and earned 0 in profits. Earnings per share was -1.75.

Revenue	400K
Gross Profit	n/a
Operating Income	-18.38M
Net Income	n/a
EBITDA	-18.38M
EBIT	n/a
Earnings Per Share (EPS)	-1.75

Full Income Statement

Balance Sheet

The company has 8.58M in cash and 2.74M in debt, giving a net cash position of 5.84M.

Cash & Cash Equivalents	8.58M
Total Debt	2.74M
Net Cash	5.84M
Retained Earnings	-332.22M
Total Assets	19.1M
Working Capital	663K

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -15.3M and capital expenditures -16K, giving a free cash flow of -15.32M.

Operating Cash Flow	-15.3M
Capital Expenditures	-16K
Free Cash Flow	-15.32M
FCF Per Share	-1.46

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-4594.25%
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	-4594.25%
EBIT Margin	-4594.25%
FCF Margin	-3830%

Dividends & Yields

IBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for IBIO is $5.5, which is 525% higher than the current price. The consensus rating is "Buy".

Price Target	$5.5
Price Target Difference	525%
Analyst Consensus	Buy
Analyst Count	2

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on Nov 29, 2023. It was a backward split with a ratio of 1:20.

Last Split Date	Nov 29, 2023
Split Type	backward
Split Ratio	1:20

Scores

Altman Z-Score	-25.64
Piotroski F-Score	2